Pregled bibliografske jedinice broj: 457593
METABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN MORPHOLOGY
METABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN MORPHOLOGY // Diabetologia Croatica, 39 (2010), 1; 9-13 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 457593 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
METABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN MORPHOLOGY
Autori
Alebić, Miro Šimun ; Duvnjak, Lea
Izvornik
Diabetologia Croatica (0351-0042) 39
(2010), 1;
9-13
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
polycystic ovary syndrome; polycystic ovarian morphology; metabolic risk markers; hyperandrogenism
Sažetak
Polycystic ovary syndrome (PCOS) is a common endocrine condition in women of reproductive age, which is associated with a range of metabolic implications. Data concerning metabolic features of patients with polycystic ovarian morphology (POM) without any other PCOS diagnostic criteria (nonPCOS-POM) are limited. In the present study, metabolic profile of 46 women with nonPCOS-POM was investigated in comparison with 36 women with PCOS D phenotype and control group (N=146). PCOS D phenotype was defined according to the European Society for Human Reproduction and Embryology/American Society for Reproductive Medicine (ESHRE/ASRM) criteria as irregular anovulatory periods and POM. NonPCOS-POM patients in comparison to PCOS-D phenotype group showed a significantly lower waist circumference (73.0 ; 17.0 ; 99.5 ; 11.0 ; P<0.001), a homeostatic model assessment of insulin resistance (HOMA-IR) (1.1 ; 1.0 ; 12.8 ; 6.9 ; P<0.001) and a significantly higher fasting glucose-insulin ratio (FGIR) (15.2 ; 13.0 ; 5.9 ; 3.4 ; P<0.001). There was no significant difference in waist circumference, FGIR and HOMAIR between the nonPCOS-PMO and control group. As neither PCOS-D phenotype nor nonPCOS-POM patients are characterized by hyperandrogenism, our data suggest that hyperandrogenism is not the only factor contributing to the increased metabolic risk in women with PCOS D phenotype. NonPCOS-POM patients share a similar metabolic risk profile with the control population and could not be considered as patients with an increased metabolic risk.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
045-1080230-0516 - Metabolički sindrom u šećernoj bolesti tipa 1 (Smirčić-Duvnjak, Lea, MZOS ) ( CroRIS)
Ustanove:
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
Uključenost u ostale bibliografske baze podataka::
- BIOSIS Previews (Biological Abstracts)
- EMBASE (Excerpta Medica)
- Scopus
- Open Science Directory
- EBSCO Bibliographic Databases